Maravai LifeSciences Holdings Inc at UBS Global Healthcare Virtual Conference Transcript
Good afternoon. Welcome. I'm Dan Brennan. I cover tools and diagnostics in the pharma service stocks here for UBS. Pleased to be joining the virtual stage here with the senior management team of Maravai, who became public back in -- I believe, it was December, and we were involved on that IPO. End of day 2 of the conference, but certainly really looking forward to digging into the story with both Carl Hull, the CEO; and Kevin Herde, the Chief Financial Officer.
Carl, you'll be able to hear on the phone. Kevin, you'll be able to see on video. Please feel free -- for those on the webcast, if you'd like to try to shoot me a question in the webcast question link, please do so, and I'll check it throughout the presentation.
So first off, I would just say, Carl and Kevin, thanks for joining us here at the UBS conference.
Well, thanks for having
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |